HRES 787
115th Congress
House
Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act…
Official title: Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from c… Show full official titleShow less
Official title: Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.
Everywhere this bill has been
11 steps
Introduced
In committee
Reported out
Agreed to (House)
Mar 20, 2018
Motion to reconsider laid on the table Agreed to without objection.
Mar 20, 2018
On agreeing to the resolution Agreed to by recorded vote: 225 - 183 (Roll no. 118). (text: CR H1704)
Mar 20, 2018
On ordering the previous question Agreed to by the Yeas and Nays: 233 - 181 (Roll no. 117). (consideration: CR H1704; text: CR H1704)
Mar 20, 2018
Considered as unfinished business.
Mar 20, 2018
POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 787, the Chair put the question on ordering the previous question and by voice vote announced that the ayes had prevailed. Mr. Hastings demanded the yeas and nays, and the Chair postponed further proceedings on the question of ordering the previous question until later in the legislative day.
Mar 20, 2018
DEBATE - The House proceeded with one hour of debate on H. Res. 787.
Mar 20, 2018
Considered as privileged matter. (consideration: CR H1704-1710)
Mar 19, 2018
Placed on the House Calendar, Calendar No. 133.
Mar 19, 2018
The resolution provides for one hour of debate on each bill. The resolution makes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H. Res. 5.
Mar 19, 2018
The House Committee on Rules reported an original measure, H. Rept. 115-613, by Mr. Burgess.
Mar 19, 2018
Introduced in House
Votes taken on this bill
2
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Mar 20, 2018 | House · vote #118 | On Agreeing to the Resolution | Passed | 225–183 | See who voted → |
| Mar 20, 2018 | House · vote #117 | On Ordering the Previous Question | Passed | 233–181 | See who voted → |
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Motion to reconsider laid on the table Agreed to without objection.
Related & companion bills
2
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). H. Res. 787: Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.. 115th Congress. Open America. https://openamerica.io/bill/115-HRES-787/
"H. Res. 787: Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HRES-787/.
H. Res. 787, 115th Cong. (2026), https://openamerica.io/bill/115-HRES-787/.
[H. Res. 787: Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.](https://openamerica.io/bill/115-HRES-787/)